ICS+LABA Vs. ICS+LABA+Omalizumab: Impact on Asthma Control and Gene Expression

NCT06869382 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Asthma Patients

Interventions

DRUG: Foster BDP/Formoterol
DRUG: Omalizimab

Sponsor

Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation